# Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Symptom Severity, Sleep Quality, Central Sensitization, and Kinesiophobia in Fibromyalgia

> **NCT07173400** · NA · COMPLETED · sponsor: **Hatice Betigul Meral** · enrollment: 30 (actual)

## Conditions studied

- Fibromyalgia (FM)
- Chronic Pain

## Interventions

- **DEVICE:** Active Transcutaneous Auricular Vagus Nerve Stimulation (TaVNS)
- **DEVICE:** Sham Transcutaneous Auricular Vagus Nerve Stimulation

## Key facts

- **NCT ID:** NCT07173400
- **Lead sponsor:** Hatice Betigul Meral
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-01
- **Primary completion:** 2025-10-10
- **Final completion:** 2025-10-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07173400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07173400, "Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Symptom Severity, Sleep Quality, Central Sensitization, and Kinesiophobia in Fibromyalgia". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT07173400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*